·¬ΗΡΚΣΖ΅

Meeting Coverage

AASLD

American Association for the Study of Liver Diseases

PPAR Agonist Led to 'Clinically Meaningful' Improvement in PBC-Related Pruritus

Seladelpar also improved markers of disease activity versus placebo

AASLD over a photo of Hynes Convention Center in Boston, Massachusetts

Latest AASLD Meeting Coverage

Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial

At highest dose, thyroid hormone receptor-beta agonist decreased liver fat content by 45%

November 15, 2023
Emergency Liver Transplant Effective for Severe Acute-on-Chronic Liver Failure

1-year survival reached 78% for patients who received an emergency transplant

November 14, 2023
Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis

In randomized trial, oral elafibranor induced biochemical response at 1 year in 51% of patients

November 14, 2023
AKI Response Tied to Improved Survival for Patients Waiting on Liver Transplant

Results highlight the importance of prompt recognition and treatment of acute kidney injury

November 13, 2023
MASLD Predicted to Increase by 23% by Middle of the Century

AASLD president: "No way we are going to be able to transplant our way out of this"

November 12, 2023
Will Fresh Look at Obeticholic Acid Data in NASH Sway FDA?

Latest REGENERATE analysis comes on heels of REVERSE flop

November 11, 2022
Steroids and G-CSF Boost 90-Day Survival in Severe Alcoholic Hepatitis

Plus: Normothermic machine perfusion for liver transplants and Noom Weight for NASH

November 11, 2022
Novel Hepatitis B Drug Hints at Long-Term 'Functional Cure' for Some in Early Trial

With 10% efficacy at 6 months post-treatment, a finite HBV treatment may be on the horizon

November 10, 2022
Efruxifermin Led to NASH Resolution, Fibrosis Improvement in Mid-Stage Trial

Both 50- and 28-mg doses improved fibrosis vs placebo, without worsening of NASH

November 10, 2022
Maralixibat Takes Out the Itch of Rare Liver Disease

Ileal bile acid transporter inhibitor could become second drug for PFIC

November 9, 2022
Odevixibat Shows 'Encouraging Results' for Kids With Alagille Syndrome

Significant improvements in itching, bile acid levels for rare, life-threatening liver disorder

November 9, 2022
Acamprosate Appears Safe for People With AUD and Liver Disease

Phase II data suggest drug is well-tolerated and can reduce cravings in this group of patients

November 9, 2022
Tenofovir, Vaccine Combo Eliminates Mom-to-Child HBV Transmission

100% success rate even without the use of hepatitis B immunoglobulin

November 7, 2022
BP Control Beneficial for Liver Transplant Recipients

Patients who kept their blood pressure under 140/90 mm Hg had better kidney function at 1 year

November 7, 2022